News
Healthcare distributor and services company Cardinal Health (NYSE:CAH) missed Wall Street’s revenue expectations in Q2 CY2025 ...
Cardinal Health today reported fourth quarter fiscal year 2025 revenues of $60.2 billion, relatively flat compared to the ...
Cardinal Health, Inc. is rated a Buy with a $239 fair value, driven by specialty growth in autoimmune, urology & oncology.
Cardinal Health is making another big move in specialty healthcare, agreeing to acquire Solaris Health for $1.9 billion. The ...
Cardinal Health reported steady fourth-quarter results and a stronger profit outlook for 2026, while expanding its specialty care platform with the acquisition of Solaris Health.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results